Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Axxam transferred undisclosed assets to Acousia's R&D programs. Acousia is developing small molecules to treat sensorineural hearing loss and to prevent hearing loss in at-risk patients. Last month, A...
BCIQ Company Profiles
Acousia Therapeutics GmbH
Axxam S.p.A.